A pilot randomized controlled trial on the effectiveness of a ‘lung age’ intervention on smoking cessation: study protocol

2015 ◽  
Vol 71 (10) ◽  
pp. 2426-2434 ◽  
Author(s):  
Imran Muhammad ◽  
Wenqi Mok ◽  
Hai Moy Toh ◽  
Daniel Sii ◽  
Wenru Wang
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Study Protocol ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Lung Age ◽  
Pilot Randomized Controlled Trial

scholarly journals A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, D.C. metropolitan area

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Elexis C. Kierstead ◽  
Emily Harvey ◽  
Denisse Sanchez ◽  
Kimberly Horn ◽  
Lorien C. Abroms ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Self Efficacy ◽  
Text Messaging ◽  
Controlled Trial ◽  
P Value ◽  
People Living With Hiv ◽  
Randomized Controlled ◽  
Living With Hiv ◽  
Pilot Randomized Controlled Trial

Abstract Objective Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. We conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model. We compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging. Results The primary outcome was smoking cessation. Secondary outcomes included cigarettes per day (CPD), exhaled carbon monoxide (CO), and cessation self-efficacy. A total of 25 participants were enrolled (TI:11, SOC:14), and 2 were lost to follow-up. There were no significant differences in quit rates between study groups. However, there was a significantly greater decrease in CPD in the TI versus SOC (13.5 vs. 0.0, p-value:0.036). Additionally, self-efficacy increased in both groups (TI p-value:0.012, SOC p-value:0.049) and CO decreased in both groups (TI p-value: < 0.001, SOC p-value:0.049). This intervention shows promise to support smoking cessation among PLWH. A larger study is needed to fully evaluate the efficacy of this approach. Clinical trial: Trial Registration: Retrospectively registered (10/20/2020) NCT04594109.

scholarly journals Approach bias retraining to augment smoking cessation: Study protocol for a randomized controlled trial

2019 ◽  
Vol 14 ◽  
pp. 100340
Author(s):  
Jasper A.J. Smits ◽  
Scarlett O. Baird ◽  
Mike Rinck ◽  
David Rosenfield ◽  
Christopher G. Beevers ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Study Protocol ◽  
Controlled Trial ◽  
Approach Bias ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document